Dan Boyarsky

Director, Life Sciences Revenue Contract Management at RSM US LLP

Speaker

Dan provides consultation services to pharmaceutical manufacturers in regard to government pricing, government compliance, commercial contracting strategy, and launch strategy. He has helped more than 20 companies launch pharmaceutical products in the recent past. Dan has his roots in the pharma industry working for Boehringer-Ingelheim Pharmaceuticals Incorporated for more than 11 years in the market access division. Prior to joining RSM US, Dan consulted pharmaceutical manufacturers for two years at Cumberland Consulting Group recently acquired by Integrichain.

Dan brings a wealth of experience in GTN build and forecasting, government pricing, claims processing, state price transparency reporting, price increase analytics, managed care analytics, and a number of other areas.